2010
Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer
Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS. Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer. Journal Of Clinical Oncology 2010, 28: 936-941. PMID: 20085934, PMCID: PMC2834433, DOI: 10.1200/jco.2009.25.5711.Peer-Reviewed Original ResearchConceptsEarly-stage NSCLCPlasma osteopontin levelsPlasma OPN levelsOPN levelsEnzyme-linked immunosorbent assayPlasma OPNOsteopontin levelsWeeks postsurgeryElevated Plasma Osteopontin LevelsCell lung cancer correlatesUse of thoracotomyCell lung cancerLung cancer correlatesCancer-free smokersResectable NSCLCPerioperative eventsTumor characteristicsPresurgery levelsRecurrence rateValidation cohortLung cancerCancer correlatesTherapeutic responseNSCLCIndependent cohort
2009
Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer (NSCLC)
Blasberg J, Pass H, Flores R, Donington J. Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2009, 27: 11019-11019. DOI: 10.1200/jco.2009.27.15_suppl.11019.Peer-Reviewed Original ResearchNon-small cell lung cancerEarly-stage non-small cell lung cancerStage non-small cell lung cancerEarly-stage NSCLC patientsStage NSCLC patientsPlasma osteopontin levelsNSCLC patientsOPN levelsPlasma OPNOsteopontin levelsIndependent cohortElevated Plasma Osteopontin LevelsStage I patientsImpact of surgeryCell lung cancerResectable NSCLC patientsSignificant decreaseNSCLC correlatesFormer smokersI patientsPrognostic significanceValidation cohortLung cancerPatientsMultivariate analysis